东瀛游(06882.HK):下午将免费派发千八个口罩 港人优先
东瀛游(06882.HK)在官方Facebook公布,眼见疫情蔓延,香港口罩严重缺货,会率先系今日(31日)下午4时30分为香港市民免费派发共1,800个合规格口罩,地点为尖沙咀漆咸道南45-51号 其士大厦5楼(尖沙咀地铁站B2出口)。
派发细则:每位可获5个口罩,合共360个名额,并会以派筹形式进行,额满即止,以免人流聚集。今次派发以香港人优先。
东瀛游指,公司管理层启动危急应变小组,近日马不停蹄地联络日韩合作夥伴,至今成功找到2万个口罩,并想尽办法用最迅速方式运抵香港,解决市民燃眉之急。衷心感谢日本茨城县、德岛县及鹿儿岛县政府,以及前线同事全力帮忙搜罗到第一批口罩。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.